Literature DB >> 16198491

The GABA rho1 subunit interacts with a cellular retinoic acid binding protein in mammalian retina.

X-Q Song1, F Meng, D J Ramsey, H Ripps, H Qian.   

Abstract

Interactions between the intracellular domain of ligand-gated membrane receptors and cytoplasmic proteins play important roles in their assembly, clustering, and function. In addition, protein-protein interactions may provide an alternative mechanism by which neurotransmitters activate intracellular pathways. In this study, we report a novel interaction between the GABA rho1 subunit and cellular retinoic acid binding protein in mammalian retina that could serve as a link between the GABA signaling pathway and the control of gene expression in neurons. The interaction between the intracellular loop of the human GABA rho subunit and cellular retinoic acid binding protein was identified using a CytoTrap XR yeast two-hybrid system, and was further confirmed by co-precipitation of the human GABA rho subunit and cellular retinoic acid binding protein from baboon retinal samples. The cellular retinoic acid binding protein binding domain on the human rho1 subunit was located to the C-terminal region of human GABA rho subunit, and the interaction of the human GABA rho subunit with cellular retinoic acid binding protein could be antagonized by a peptide derived from within the binding domain of the rho1 subunit. Since cellular retinoic acid binding protein is a carrier protein for retinoic acid, we investigated the effect of GABA on retinoic acid activity in neuroblastoma cells containing endogenously expressed cellular retinoic acid binding protein. In the absence of the rho1 receptor, these cells showed enhanced neurite outgrowth when exposed to retinoic acid and GABA had no effect on their response to retinoic acid. In contrast, cells stably transfected with the human rho1 subunit showed a significantly reduced sensitivity to retinoic acid when exposed to GABA. These results suggest that the GABA receptor subunit effectively altered gene expression through its interaction with the cellular retinoic acid binding protein pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16198491     DOI: 10.1016/j.neuroscience.2005.08.018

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  9 in total

1.  Retinoic acid, GABA-ergic, and TGF-beta signaling systems are involved in human cleft palate fibroblast phenotype.

Authors:  Tiziano Baroni; Catia Bellucci; Cinzia Lilli; Furio Pezzetti; Francesco Carinci; Ennio Becchetti; Paolo Carinci; Giordano Stabellini; Mario Calvitti; Eleonora Lumare; Maria Bodo
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

2.  2-Aminoethyl methylphosphonate, a potent and rapidly acting antagonist of GABA(A)-ρ1 receptors.

Authors:  An Xie; Jun Yan; Lan Yue; Feng Feng; Fozia Mir; Heba Abdel-Halim; Mary Chebib; Guy C Le Breton; Robert F Standaert; Haohua Qian; David R Pepperberg
Journal:  Mol Pharmacol       Date:  2011-08-02       Impact factor: 4.436

3.  Tax1-binding protein 1 is expressed in the retina and interacts with the GABA(C) receptor rho1 subunit.

Authors:  Melanie Ulrich; Silke Seeber; Cord-Michael Becker; Ralf Enz
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

4.  Pharmaceutical intervention for myopia control.

Authors:  Prema Ganesan; Christine F Wildsoet
Journal:  Expert Rev Ophthalmol       Date:  2010-12-01

Review 5.  Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians.

Authors:  Elisabeth Chroni; Alexandra Monastirli; Dionysios Tsambaos
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

6.  Novel, potent, and selective GABAC antagonists inhibit myopia development and facilitate learning and memory.

Authors:  Mary Chebib; Tina Hinton; Katrina L Schmid; Darren Brinkworth; Haohua Qian; Susana Matos; Hye-Lim Kim; Heba Abdel-Halim; Rohan J Kumar; Graham A R Johnston; Jane R Hanrahan
Journal:  J Pharmacol Exp Ther       Date:  2008-11-04       Impact factor: 4.030

7.  Streptozotocin-induced diabetes modulates GABA receptor activity of rat retinal neurons.

Authors:  David J Ramsey; Harris Ripps; Haohua Qian
Journal:  Exp Eye Res       Date:  2007-06-19       Impact factor: 3.467

8.  An Update on GABAρ Receptors.

Authors:  Gustavo Martínez-Delgado; Argel Estrada-Mondragón; Ricardo Miledi; Ataúlfo Martínez-Torres
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

Review 9.  Neurovascular interaction and the pathophysiology of diabetic retinopathy.

Authors:  Haohua Qian; Harris Ripps
Journal:  Exp Diabetes Res       Date:  2011-02-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.